The Challenge of Change - Managing Excipients Control
Colorcon
08-Jun-2011 - April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers.
08-Jun-2011 - Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.
08-Jun-2011 - BARDA is extending its botulism antitoxin supply contract with Cangene, adding $61m (€42m) to the value of the deal over the next three to four years.
01-Jun-2011 - Bilfinger Berger has won a €30m ($43m) contract to help Genzyme add 8,000L of production capacity at its site in Geel, Belgium.
01-Jun-2011 - Ashland will buy International Specialty Products (ISP) in a deal designed to expand it's business in less cyclical, high-growth markets such as pharmaceuticals and personal care.
30-May-2011 - From July the EC will require that gelatin used in parenteral drugs is sourced from countries in World Organisation for Animal Health's (OIE) lowest risk categories for bovine spongiform encephalopathy (BSE).
30-May-2011 - German transdermal drug developer, Labtec, has opened what it claims is Europe’s most modern manufacturing facility for the production of transdermal drug delivery systems (TDS) and oral dispersible films (ODF) using its proprietary RapidFilm technology.
26-May-2011 - PolyPid claims its new polymer-lipid combination delivery tech will let pharmas set precise release characteristics for a variety of small molecule, protein and nucleic acid-base drugs.
26-May-2011 - Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.
26-May-2011 - 3M Drug Delivery has developed a transdermal delivery technology for an osteoporosis treatment being trialled by Radius Health.
24-May-2011 - Serina Therapeutics has developed a new way of synthesizing polyoxazoline (POZ) polymers for drug delivery applications that, it claims, is free of the drawbacks that have hampered previous production methods.
24-May-2011 - Sigma-Aldrich has strengthened in Latin America by acquiring a Brazilian manufacturing and laboratory chemical supplier.
23-May-2011 - SAFC, the custom manufacturing and business services wing of Sigma Aldritch, has announced a licensing agreement with biotech company, Agilent Technologies, for the sale of its nucleic acids synthesis products and technologies.
23-May-2011 - Struggling drug delivery systems developer Vyteris wants to sell its transdermal technology business and go on a CRO buying spree.
23-May-2011 - Neuland Laboratories doubled its operating profit in the fourth quarter, continuing the full year trend, as API sales improved.
19-May-2011 - Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid (HA) for ophthalmic delivery applications later this year.
19-May-2011 - Alkermes saw losses increase in fiscal 2011 but has issued an upbeat outlook on higher revenues, portfolio expansion and impending acquisition of Elan Drug Technologies (EDT).
18-May-2011 - Californian biotech tool manufacturer Life Technologies has teamed with German contract research organisation (CRO) ProBiogen to release a range of royalty-free Gibco Freedom Cell Line Development Kits.
16-May-2011 - Biovest International has completed construction of its personalised cancer vaccine production suites in Minnesota, US.
16-May-2011 - Work towards manufacturing scale-up of a smallpox antiviral has been suspended after a protest was filed against award of the US government contract.
11-May-2011 - Jubilant Life Sciences is to build an intermediate plant and expand production to continue double-digit growth seen in the fourth quarter.
11-May-2011 - Aurobindo Pharma is considering demerging its API and formulation businesses to unlock value and better serve clients.
10-May-2011 - Chemicals supplier Aceto Corp has its sights set on opportunities in the generic drug sector after soaring active pharmaceutical ingredient (API) and intermediates sales helped it to a strong set of quarterly financials.
09-May-2011 - Elan will sell its delivery technology unit, EDT, to Alkermes in a deal that brings to an end the Irish drugmakers’ long search for a buyer.
09-May-2011 - Cambrex recorded double-digit sales growth in the first quarter as the API producer overcame problems it faced a year ago.